From Nasdaq:

Looking to boost your portfolio this year? Innovative stocks can lead the way. CRISPR Therapeutics is a game changer, gaining approval for its gene-editing therapy. Ginkgo Bioworks engineers organisms for improved products, with revenue rising 36%. Alphabet’s stock has room to run, with Google’s strong ad revenue and advancements in AI. Teladoc Health is shifting focus to balance growth and profitability. Tesla could continue its winning streak with strategic investments and a growing cash position.



Read more: 5 Innovative Stocks That Could Score a Win for Your Portfolio in 2024